Ming Li in Mission Viejo, California

Home California Mission Viejo

Ming Li has Hematology/oncology as his primary medical specialty. Their primary office is: 27799 Medical Ctr Rd in Mission Viejo, California.

They're a part of the: Providence Medical Foundation medical group which has around 1,270 members. You can call their office at 949-364-5090 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Tulane University School Of Medicine and graduated in 2012 (around 12 years of experience). They are listed as doing telehealth appointments.

Ming Charles Li Office Phone and Directions

Ming Li
Providence Medical Foundation
27799 Medical Ctr Rd
Mission Viejo, California 92691
949-364-5090

Patient Ratings
Please rate your experience with Ming Li below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 949-364-5090

Enter a starting address:

Healthcare Info for Ming Li

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Tulane University School Of Medicine
Graduation Year: 2012
The Primary Medical Specialty for Ming Li is listed as: Hematology/oncology
Approximate Years of Experience: 12
PAC (PECOS ID)#: 0042442386
NPI #: 1770843054
NPI Created On: 05/21/2012
NPI Last Updated Listed as: 11/05/2021
Primary Taxonomy Code: 207RH0003X
License Number:
A127280
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Blood test, comprehensive group of blood chemicals
Ferritin (blood protein) level
Iron level
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $36

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667931

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667933

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667935

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $33

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667937

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667941

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667939

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667943

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667945

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Hematology/oncology Professionals in Mission Viejo

1.
Tariq Mahmood

27799 Medical Ctr Rd
Mission-viejo, CA
Providence Medical Foundation

2.
Edward Wagner MD

23512 Madero
Mission-viejo, CA
Memorialcare Medical Foundation

3.
Sarah Hassan

23512 Madero
Mission-viejo, CA
Memorialcare Medical Foundation

4.
George Miranda

27799 Medical Ctr Rd
Mission-viejo, CA
Providence Medical Foundation

5.
Minch Fong

27799 Medical Ctr Rd
Mission-viejo, CA
Providence Medical Foundation

6.
Jack Jacoub

23512 Madero
Mission-viejo, CA
Memorialcare Medical Foundation

Providers in Providence Medical Foundation

1.Lea Dominique Abadies

1950 Sunny Crest Dr
Fullerton Ca 92835-3641
Providence Medical Foundation
Physician Assistant

2.Sonja Abbassi

27799 Medical Ctr Rd
Mission Viejo Ca 92691-6400
Providence Medical Foundation
Internal Medicine

3.Sonja Abbassi

1950 Sunny Crest Dr
Fullerton Ca 92835-3641
Providence Medical Foundation
Internal Medicine

4.Shenoda Abd Elmaseh

27799 Medical Ctr Rd
Mission Viejo Ca 92691-6400
Providence Medical Foundation
Family Practice

5.Shenoda Abd Elmaseh

1950 Sunny Crest Dr
Fullerton Ca 92835-3641
Providence Medical Foundation
Family Practice

6.Abdul Abdali

2700 Dolbeer St
Eureka Ca 95501-4736
Providence Medical Foundation
Hospitalist

View all 1,270 members of Providence Medical Foundation medical group